IRVINE, Calif., Oct. 12, 2016 -- Global Vision Holdings, Inc. (OTCQB:GVHIB), has signed a Letter of Intent, after extensive due diligence, for the acquisition of North Delta Hospice and Palliative Services, LLC (NDHP); a Form 8-K has been filed to that effect.
NDHP is the only in-patient care facility located in northern Mississippi. Standing for quality care, the company provides services to patients living with terminal illness. Amenities include social, adult day care, chaplain, volunteer, personal care, therapy, bereavement and counseling, and skilled nursing services to all clients. Averaging 1500 patients and 150 admissions monthly, NDHP is a long-standing company that has achieved success and growth through excellent health care services. Also, operates multiple moratorium licenses in the state of Mississippi. All medical equipment needs are in-house through its own division, offering a cost effective alternative to contracting out. Having an additional state waiver program license with no active census gives them a competitive edge in the industry.
Glen Carnes, CEO of Global Vision Holdings, Inc. says, “North Delta Hospice and Palliative Services will be the start of our long-term growth strategy into the Healthcare Industry. I am extremely excited to acquire NDHP as a new subsidiary under the Global Vision brand. This acquisition will play a pivotal role in the long-term strategic growth strategy of 2-4 healthcare acquisitions per year."
Global Vision Holdings Inc. will continue to inform you of business developments, with mergers and acquisitions, as they arise.
About Global Vision Holdings Inc.
Headquartered in Irvine, California, Global Vision Holdings Inc. is a diversified financial investment company that evaluates acquisition and investment opportunities. Currently, the Company is focusing on the market domain of Healthcare that is profitable, growing, and environmentally responsible. Global Vision Holdings Inc. uses a superior team of financial research experts and in-house environmentally responsible analysis to make recommendations for strategic acquisitions. For more information, please visit our website at www.globalvisionholdings.net.
Cautionary Statement Regarding Forward-Looking Statements
This release may include forward-looking statements. These forward-looking statements are based on current expectations that involve risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual results may differ materially. These risks include: changes in business or other market conditions; the challenge of managing asset/liability levels; the difficulty of keeping expense growth at modest levels while increasing revenues; unforeseen challenges with respect to product development and the timing thereof; integration efforts relating to our acquisition activities; uncertainties regarding financing efforts which may be undertaken by the Company; and other risks detailed from time to time in the Company’s Securities and Exchange Commission reports, including but not limited to the Annual Report on Form 10-K for the most recent year ended. Pursuant to the Private Securities Litigation Reform Act of 1995, the Company does not undertake to update forward-looking statements contained within this news release.
Contact Information: Glen Carnes Chairman and CEO Global Vision Holdings, Inc. 714-348-0605 [email protected]


Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 



